EBCC15: Axillary Radiotherapy Shows Promise as Less Invasive Alternative to Lymph Node Surgery for Breast Cancer Patients
New ADARNAT trial data shows axillary radiotherapy may be as effective as surgery for limited lymph node cancer, with lower risks of chronic arm swelling.
By: AXL Media
Published: Mar 26, 2026, 9:06 AM EDT
Source: Information for this report was sourced from European Organisation for Research and Treatment of Cancer
HEADLINE
EBCC15: Axillary Radiotherapy Shows Promise as Less Invasive Alternative to Lymph Node Surgery for Breast Cancer Patients
SUMMARY
Preliminary results from the ADARNAT phase III trial, presented at the 15th European Breast Cancer Conference, suggest that axillary radiotherapy (ART) may be as effective as surgical dissection (ALND) for patients whose cancer has spread to limited lymph nodes after chemotherapy. The pilot study indicates that while radiotherapy causes temporary skin redness, it may reduce the long-term risk of lymphedema and functional arm complications.
CONTENT
De-escalating Surgical Intervention in the Axilla
Categories
Topics
Related Coverage
- Largest Study of its Kind Confirms Circulating Tumor DNA as a Potent Predictor of Breast Cancer Relapse Following Pre-Surgery Therapy
- Groundbreaking Research at EBCC15 Shows Circulating Tumor DNA Post-Treatment Predicts Breast Cancer Relapse Risk
- Study of 1,400 Patients Shows Polyurethane-Coated Implants Significantly Cut Scarring Risks After Post-Mastectomy Radiotherapy
- Maastro Study of 800 Patients Reveals Personalized Radiotherapy Safely Minimizes Treatment Without Increasing Breast Cancer Recurrence